Brachytherapy
Volume 8, Issue 4 , Pages 367-372 , October 2009

Initial clinical experience with the Strut-Adjusted Volume Implant brachytherapy applicator for accelerated partial breast irradiation

  • Catheryn M. Yashar

      Affiliations

    • Department of Radiation Oncology, University of California San Diego, La Jolla, CA
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, University of California San Diego, Moores Cancer Center, 3855 Health Sciences Drive #0843, La Jolla, CA 92093-0843. Tel.: +1-858-822-6059; fax: +1-858-822-5568.
    • ,
  • Sarah Blair

      Affiliations

    • Department of Surgery, Division of Surgical Oncology, University of California San Diego, La Jolla, CA
    • ,
  • Anne Wallace

      Affiliations

    • Department of Surgery, Divisions of Plastics and Surgical Oncology, University of California San Diego, La Jolla, CA
    • ,
  • Dan Scanderbeg

      Affiliations

    • Department of Radiation Oncology, University of California San Diego, La Jolla, CA

Received 11 February 2009 ,Revised 24 March 2009 ,Accepted 26 March 2009.

References 

  1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232
  3. Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early stage invasive cancer. Acta Oncol Suppl. 1999;13:9–17
  4. Veronesi U, Luini A, del Vecchio M, et al. Radiotherapy after breast preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328:1587–1591
  5. Fowble B, Soli LJ, Schultz DJ, et al. Breast recurrence following conservative surgery and radiation: Patterns of failure, prognosis, and pathologic finding from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 1990;19:833–842
  6. Arthur DW, Doo D, Swicker RD, et al. Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003;56:681–689
  7. Baglan KL, Martinez AA, Frazier RC, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2001;50:1003–1011
  8. Krishnan L, Jewell WR, Tawfik OW, et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 2001;7:91–96
  9. Perera F, Yu E, Engel J, et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys. 2003;57:1239–1246
  10. Polgár C, Major T, Fodor J, et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: Seven-year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004;60:1173–1181
  11. Ott OJ, Hildebrandt G, Pötter R, et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol. 2007;82:281–286
  12. Ott OJ, Pötter R, Hammer , et al. Accelerated partial breast irradiation with Iridium-192 multicatheter PDR/HDR brachytherapy: Preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol. 2004;180:642–649
  13. Strnad V, Ott OJ, Pötter R, et al. Interstitial brachytherapy after breast conserving surgery: Interim results of a German-Austrian multicenter phase II trial. Brachytherapy. 2004;3:115–119
  14. Vicini FA, Arthur DW. Breast brachytherapy: North American experience. Semin Radiat Oncol. 2005;15:108–115
  15. Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205–1211
  16. Wazer DE, Berle L, Graham R, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53:889–897
  17. Arthur DW, Winter K, Kuske RR, et al. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2008;72:467–473
  18. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is1,2) breast cancer. Am J Surg. 2000;180:299–304
  19. Fa Vicini, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993–2001
  20. Polgár C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121–128
  21. Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: A method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006;106:991–999
  22. Kuske RR, Winter K, Arthur DW, et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2006;65:45–51
  23. Polgár C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-Year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694–702
  24. Benitez PR, Keisch ME, Vicini F, et al. Five-year results: The initial clinical trial of Mammosite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:457–462
  25. Vicini F, Beitsch P, Quiet C, et al. Two year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). J Clin Oncol. 2006;18S:529
  26. Cuttino LW, Arthur DW, Keisch M, et al. Multi-institutional experience using the MammoSite Radiation Therapy System (RTS) in the treatment of early-stage breast cancer: 2 Year results. Int J Radiat Oncol Biol Phys. 2006;66:S30–S31
  27. Prestidge B, Sadeghi A, Rosenthal A, et al. Local control of early stage breast cancer using MammoSite HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2006;66:S215
  28. Chao K, Vicini F, Wallace M, et al. Analysis of treatment efficacy, cosmesis and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial breast irradiation: The William Beaumont Hospital experience. Int J Radiat Biol Oncol Phys. 2007;69:32–40
  29. Vicini FA, Chen P, Wallace M, et al. Interim cosmetic results and toxicity using 3D conformal external beam radiation therapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007;69:1124–1130
  30. Dragun AE, Harper JL, Jenrette JM, et al. Predictors of cosmetic outcome following MammoSite breast brachytherapy: A single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007;68:354–358
  31. Brashears JH, Dragun AE, Jenrette JM. Late chest wall toxicity after MammoSite((R)) breast brachytherapy. Brachytherapy. 2009;8:19–25
  32. Scanderbeg D, Yashar C, Rice R, et al. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiother Oncol. 2009;90:36–42
  33. Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatments: Impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:13–47
  34. Rose MA, Olivotto I, Cady B, et al. Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg. 1989;124:153–157
  35. Recht A, Ancukiewicz M, Lu X, et al. Lung dose-volume parameters and the risk of pneumonitis for patients treated with accelerated partial-breast irradiation (APBI) using 3D conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2008;72:S4
  36. Hepel J, Tokita M, MacAusland S, et al. Toxicity of 3D-CRT for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2008;72:S5

PII: S1538-4721(09)00247-5

doi: 10.1016/j.brachy.2009.03.190

Brachytherapy
Volume 8, Issue 4 , Pages 367-372 , October 2009

Article Tools

* Image Usage & Resolution